Consolidation of and dependence on the market for contract testing related to hepatitis B drugs

A focus on the contraction of contract testing services related to hepatitis B drugs, which account for most of sales, due to market consolidation and declining demand, and the resulting impact on CRO business revenue. It addresses concentrated dependence on the contract testing market in a specific disease area.